automated geriatric co-management for Cancer

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Cancerautomated geriatric co-management - Other
Eligibility
65+
All Sexes
What conditions do you have?
Select

Study Summary

This trial will test if an automated geriatric care program can manage patients before, during, and after surgery.

Treatment Effectiveness

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: 2 years

2 years
feasibility of automated geriatric co-management program

Trial Safety

Trial Design

2 Treatment Groups

In-person geriatric co-management group
1 of 2
Automated geriatric co-management program group
1 of 2

Active Control

Experimental Treatment

20 Total Participants · 2 Treatment Groups

Primary Treatment: automated geriatric co-management · No Placebo Group · N/A

Automated geriatric co-management program group
Other
Experimental Group · 1 Intervention: automated geriatric co-management · Intervention Types: Other
In-person geriatric co-management group
Other
ActiveComparator Group · 1 Intervention: in-person geriatric co-management · Intervention Types: Other

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 2 years

Who is running the clinical trial?

Memorial Sloan Kettering Cancer CenterLead Sponsor
1,832 Previous Clinical Trials
584,548 Total Patients Enrolled
Armin Shahrokni, MD, MPHPrincipal InvestigatorMemorial Sloan Kettering Cancer Center
1 Previous Clinical Trials
100 Total Patients Enrolled

Eligibility Criteria

Age 65+ · All Participants · 4 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
A solid mass or nodule that is suspicious for cancer can be a cause of concern
consideration for surgical resection of the solid mass or nodule is being given, with an anticipated hospital length of stay of at least two days.